Applications of artificial intelligence in clinical laboratory genomics.

Journal: American journal of medical genetics. Part C, Seminars in medical genetics
Published Date:

Abstract

The transition from analog to digital technologies in clinical laboratory genomics is ushering in an era of "big data" in ways that will exceed human capacity to rapidly and reproducibly analyze those data using conventional approaches. Accurately evaluating complex molecular data to facilitate timely diagnosis and management of genomic disorders will require supportive artificial intelligence methods. These are already being introduced into clinical laboratory genomics to identify variants in DNA sequencing data, predict the effects of DNA variants on protein structure and function to inform clinical interpretation of pathogenicity, link phenotype ontologies to genetic variants identified through exome or genome sequencing to help clinicians reach diagnostic answers faster, correlate genomic data with tumor staging and treatment approaches, utilize natural language processing to identify critical published medical literature during analysis of genomic data, and use interactive chatbots to identify individuals who qualify for genetic testing or to provide pre-test and post-test education. With careful and ethical development and validation of artificial intelligence for clinical laboratory genomics, these advances are expected to significantly enhance the abilities of geneticists to translate complex data into clearly synthesized information for clinicians to use in managing the care of their patients at scale.

Authors

  • Swaroop Aradhya
    Invitae Corporation, San Francisco, California, USA.
  • Flavia M Facio
    Invitae Corporation, San Francisco, California, USA.
  • Hillery Metz
    Invitae Corporation, San Francisco, California, USA.
  • Toby Manders
    Invitae Corporation, San Francisco, California, USA.
  • Alexandre Colavin
    Invitae Corporation, San Francisco, California, USA.
  • Yuya Kobayashi
    Invitae Corporation, San Francisco, California, USA.
  • Keith Nykamp
    Invitae Corporation, San Francisco, California, USA.
  • Britt Johnson
    Invitae Corporation, San Francisco, California, USA.
  • Robert L Nussbaum
    Invitae Corporation, San Francisco, California, USA.